Overhauling the US Food and Drug Administration's OTC drug monograph program depends on Congress passing legislation, something agency officials and industry stakeholders are confident will come but aren't predicting when.
The FDA and the Consumer Healthcare Products Association are preparing for changes to monograph procedures that the agency and industry...